FDA accepts two applications for generic weight loss drugs amid international competition as well as issues of patents and ...

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

Monthly sales of GLP-1 weight-loss drugs in India dipped to ₹227 crore in June from a record ₹236 crore in May, signaling a ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

The proposed framework would bring manufacturers and suppliers of printed pharmaceutical packaging materials under drug laws ...

Eli Lilly currently holds a patent on both drugs through 2036.

Many people believe that name-brand medications are better than their generic versions. But is Tylenol truly more effective ...

The GLP-1 weight-loss and diabetes drug market stabilizes as generics gain traction, with innovators maintaining steady sales ...

China's ‌Hybio Pharmaceutical said ​the ​U.S. Food and ⁠Drug ​Administration has ​accepted for reviews its abbreviated ​new ...

Granules India wins FDA sole first-to-file status for sodium oxybate extended-release ANDA, a generic of Alkermes’ LUMRYZ, ...

Mark Cuban says Cost Plus Drugs cut prices on 90 medications since joining TrumpRx, with more reductions expected as demand ...

A ruling in favor of generic drugmaker Hikma will make it harder for brand-name manufacturers to block cheaper alternatives.